MGMT and central nervous system cancer: Cimini et al. performed static 18F-FDOPA-PET/CT in 72 patients post-surgery and found no difference between the presence of MGMT methylation versus unmethylation (p = 0.15) and no difference between IDH-mutant and IDH-wildtype gliomas (p = 0.79) [72].